Every funding round OVUM has recorded in women's health, with the company, stage, disclosed amount, named investors and the source it came from. Built from the signal stream and founder-submitted profiles; amounts appear only where they were disclosed.
| Company | Stage | Amount | Date | Investors | Source |
|---|---|---|---|---|---|
| Circle Pharma Therapeutics | Series E | $93M | 2026-09-16 | The Column Group, Nextech Invest, RA Capital Management, Euclidean Capital | Source |
| ProFound Therapeutics Maternal & Newborn · Diagnostics | Grant | $35M | 2026-08-27 | — | OVUM signal |
| Opal Therapeutics Therapeutics · Digital Health/Telehealth | Grant | $1M | 2026-08-07 | — | OVUM signal |
| Rejoni Devices · Therapeutics | Series B | $25M | 2026-06-16 | — | OVUM signal |
| Celmatix Endometriosis/PCOS · Sexual & Reproductive | Series C | $80M | 2026-03-14 | — | OVUM signal |
Compiled by OVUM from public reporting and founder-submitted company profiles. Amounts are as disclosed; blanks mean no figure was published. Spot something wrong? Write to us and we'll correct it.